Literature DB >> 10945951

Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines.

L Zhang1, R E Cilley, M R Chinoy.   

Abstract

Small Cell Lung Cancer (SCLC), a clinically aggressive cancer, accounts for approximately 25% of primary lung cancers. We carried out suppression subtractive hybridization (SSH), a PCR-based method for cDNA subtraction, between the human classic, NCI-H69 and variant, more aggressive NCI-N417 SCLC cell lines to isolate and characterize variable expression of genes, which may be responsible for differential degree of tumorigenicity of SCLC. Using NCI-N417 as a tester, we obtained 28 differentially expressed cDNA clones from a total of 60 arbitrarily picked clones. Among the 28 cDNA clones, 4 were unknown genes, 2 were fatty acid binding protein (FABP) with specific identification of mRNA for mammary-derived growth inhibitor (MDGI), 1 was human alpha-enolase, 4 were ribosomal proteins, 2 were structural genes, vimentin and moesin (membrane-organizing extension spike protein), and 9 were homologous with murine leukemia viruses, whereas 2 others had enhanced expression in NCI-H69 and A549 cell lines, and 4 were cell surface proteins and murine type C retrovirus. Expression of FABP/MDGI was significantly high in NCI-H417, which may influence mitosis and cell growth as implicated in other tissues, contrary to the conclusion drawn for the role of MDGI in human breast cancer. Higher expression of ribosomal proteins in NCI-N417 compared to NCI-H69 may have a role in differential tumorigenicity and metastatic ability. Further, we obtained 14 differentially expressed cDNA clones by reversing the tester and driver, using NCI-H69 as a tester. Of these 14 differential cDNAs, 5 were unknown genes, 2 were specific for keratins, others had similarities with protease inhibitor, human BAC clone, Alu RNA binding protein, and tumor expression-enhanced gene. Characterization of these differentially expressed cDNA clones will provide useful information in understanding of the genes responsible for differential tumorigenicity of SCLC. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945951     DOI: 10.1006/jsre.2000.5957

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  13 in total

Review 1.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

2.  Construction of a hepatic stellate cells subtracted cDNA library of differentially expressed genes in normal mice and mice with Schistosomiasis japonica.

Authors:  Min Zheng; Yi-jun Wu; Wei-min Cai; Hong-lei Weng; Rong-hua Liu
Journal:  J Zhejiang Univ Sci B       Date:  2005-04       Impact factor: 3.066

3.  Construction of a metastasis-associated gene subtracted cDNA library of human colorectal carcinoma by suppression subtraction hybridization.

Authors:  Li Liang; Yan-Qing Ding; Xin Li; Guang-Zhi Yang; Jun Xiao; Li-Chun Lu; Jin-Hua Zhang
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

4.  cDNA suppression subtraction library for screening down-regulated genes in gastric carcinoma.

Authors:  Jian-Jun Du; Ke-Feng Dou; Shu-You Peng; Hua-Sheng Xiao; Wei-Zhong Wang; Wen-Xian Guan; Zhong-Hua Wang; Zhi-Qing Gao; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; George J Christ; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2008-03-12       Impact factor: 5.911

6.  Novel target for peptide-based imaging and treatment of brain tumors.

Authors:  Maija Hyvönen; Juulia Enbäck; Tuulia Huhtala; Johanna Lammi; Harri Sihto; Janne Weisell; Heikki Joensuu; Katri Rosenthal-Aizman; Samir El-Andaloussi; Ulo Langel; Ale Närvänen; Gabriele Bergers; Pirjo Laakkonen
Journal:  Mol Cancer Ther       Date:  2014-02-03       Impact factor: 6.261

7.  Construction and analysis of SSH cDNA library of human vascular endothelial cells related to gastrocarcinoma.

Authors:  Yong-Bo Liu; Zhao-Xia Wei; Li Li; Hang-Sheng Li; Hui Chen; Xiao-Wen Li
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

8.  Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.

Authors:  Mariavera Lo Presti; Arianna Ferro; Flavia Contino; Claudia Mazzarella; Silvia Sbacchi; Elena Roz; Carmelo Lupo; Giovanni Perconti; Agata Giallongo; Paola Migliorini; Antonio Marrazzo; Salvatore Feo
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Overexpression of α-enolase correlates with poor survival in canine mammary carcinoma.

Authors:  Pei-Yi Chu; Nicholas C Hsu; Albert T Liao; Neng-Yao Shih; Ming-Feng Hou; Chen-Hsuan Liu
Journal:  BMC Vet Res       Date:  2011-10-21       Impact factor: 2.741

10.  Proteomic analysis of non-small cell lung cancer tissue interstitial fluids.

Authors:  Shaomin Li; Rui Wang; Mingxin Zhang; Lina Wang; Shaoli Cheng
Journal:  World J Surg Oncol       Date:  2013-08-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.